BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24482231)

  • 1. Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.
    Ma L; Wang J; Lin J; Pan Q; Yu Y; Sun F
    J Biol Chem; 2014 Mar; 289(10):6921-6933. PubMed ID: 24482231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
    Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
    Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-κB in liver cancer cell line Bel-7402.
    Ma L; Pan Q; Sun F; Yu Y; Wang J
    Biochem Biophys Res Commun; 2014 Aug; 451(2):334-8. PubMed ID: 25094049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.
    Bartolomé RA; Pintado-Berninches L; Jaén M; de Los Ríos V; Imbaud JI; Casal JI
    Oncogene; 2020 Sep; 39(38):6085-6098. PubMed ID: 32801337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT.
    Yu W; Wang J; Ma L; Tang X; Qiao Y; Pan Q; Yu Y; Sun F
    Oncol Rep; 2014 Aug; 32(2):677-83. PubMed ID: 24891117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
    Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
    Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer.
    Xiao W; Wang J; Ou C; Zhang Y; Ma L; Weng W; Pan Q; Sun F
    Biochem Biophys Res Commun; 2013 Sep; 439(2):167-72. PubMed ID: 23994632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
    Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma.
    Huo X; Zhang Q; Liu AM; Tang C; Gong Y; Bian J; Luk JM; Xu Z; Chen J
    Oncol Rep; 2013 Feb; 29(2):840-6. PubMed ID: 23232767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
    Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
    Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
    Zhang Y; Yuan J; Zhang X; Yan F; Huang M; Wang T; Zheng X; Zhang M
    Oncol Rep; 2016 Dec; 36(6):3619-3626. PubMed ID: 27779692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.
    Fan Z; Xia H; Xu H; Ma J; Zhou S; Hou W; Tang Q; Gong Q; Nie Y; Bi F
    Biomed Pharmacother; 2018 Jul; 103():147-156. PubMed ID: 29649630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
    Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
    Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
    Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
    Ge JC; Wang YX; Chen ZB; Chen DF
    Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.